Patents by Inventor Steven R. Carlson

Steven R. Carlson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6776992
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: July 29, 2002
    Date of Patent: August 17, 2004
    Assignee: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Publication number: 20040151740
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: June 12, 2003
    Publication date: August 5, 2004
    Inventors: Kei Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Publication number: 20040126396
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: May 21, 2003
    Publication date: July 1, 2004
    Applicant: Allergan, Inc.
    Inventors: Kei Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Publication number: 20040126397
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: December 2, 2003
    Publication date: July 1, 2004
    Applicant: Allergan, Inc.
    Inventors: Kei Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Publication number: 20040037852
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: May 21, 2003
    Publication date: February 26, 2004
    Applicant: Allergan, Inc.
    Inventors: Kei Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Patent number: 6683049
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: January 27, 2004
    Assignee: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Publication number: 20040014663
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: June 12, 2003
    Publication date: January 22, 2004
    Inventors: Kei Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Publication number: 20040013692
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: July 16, 2003
    Publication date: January 22, 2004
    Applicant: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Patent number: 6645496
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: November 11, 2003
    Assignee: Allergan Sales, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Patent number: 6632433
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: June 18, 2001
    Date of Patent: October 14, 2003
    Assignee: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Publication number: 20020197279
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: July 29, 2002
    Publication date: December 26, 2002
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Patent number: 6458365
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: January 19, 2000
    Date of Patent: October 1, 2002
    Assignee: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Publication number: 20020010138
    Abstract: A method of treating a patient suffering from a disease, disorder or condition includes the administration to the patient of a therapeutically effective amount of botulinum toxin of a selected serotype until the patient experiences loss of clinical response to the administered botulinum toxin and thereafter administering to the patient a therapeutically effective amount of another botulinum toxin of a different serotype.
    Type: Application
    Filed: April 30, 2001
    Publication date: January 24, 2002
    Applicant: Allergan Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Publication number: 20020006905
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: July 16, 2001
    Publication date: January 17, 2002
    Applicant: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Publication number: 20020001592
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: June 18, 2001
    Publication date: January 3, 2002
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Publication number: 20010053364
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: July 11, 2001
    Publication date: December 20, 2001
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Publication number: 20010043930
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: June 18, 2001
    Publication date: November 22, 2001
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Patent number: 6319505
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: November 20, 2001
    Assignee: Allergan Sales, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Publication number: 20010041181
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: June 15, 2001
    Publication date: November 15, 2001
    Applicant: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Patent number: 6290961
    Abstract: A method and composition for treating a patient, suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: September 18, 2001
    Assignee: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon